TherapeuticsMD, Inc.
$2.11▼ 2.31%($-0.05)
TickerSpark Score
82/100
▌ Strong
60
Valuation
65
Profitability
100
Growth
84
Health
100
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TXMD research report →
52-Week Range57% of range
Low
$0.99
Current
$2.11
High
$2.95
Company Overviewwww.therapeuticsmd.com
About the company
TherapeuticsMD, Inc. is a U. S.
- CEO
- Marlan D. Walker
- IPO
- 2007
- Employees
- 1
- HQ
- Boca Raton, FL, US
Price Chart
+85.09% · this period
Valuation
- Market Cap
- $24.42M
- P/E
- 137.01
- P/S
- 7.28
- P/B
- 0.91
- EV/EBITDA
- -5.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 90.31%
- Op Margin
- -111.66%
- Net Margin
- 5.34%
- ROE
- 0.66%
- ROIC
- -8.10%
Growth & Income
- Revenue
- $3.02M · 71.61%
- Net Income
- $-569,000 · 73.91%
- EPS
- $-0.05 · 74.11%
- Op Income
- $-4,214,000
- FCF YoY
- 231.15%
Performance & Tape
- 52W High
- $2.95
- 52W Low
- $0.99
- 50D MA
- $2.06
- 200D MA
- $1.87
- Beta
- 0.59
- Avg Volume
- 38.04K
Get TickerSpark's AI analysis on TXMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 23, 25 | Thompson Tommy G | buy | 8,400 |
| Nov 3, 25 | Thompson Tommy G | other | 8,500 |
| Nov 3, 25 | Naughton Gail K | other | 8,500 |
| Nov 3, 25 | Collins Cooper C. | other | 8,500 |
| Nov 3, 25 | Walker Marlan D | other | 67,492 |
| Apr 14, 25 | Thompson Tommy G | buy | 325 |
| Apr 14, 25 | Walker Marlan D | buy | 490 |
| Apr 10, 25 | Walker Marlan D | buy | 1,167 |
| Apr 9, 25 | Walker Marlan D | buy | 1,136 |
| Feb 18, 25 | Collins Cooper C. | other | 8,500 |
Coverage · TXMD
Our TXMD coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on TXMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TXMD report →Internal Compare
Similar companies
Peers in the same neighborhood.